Search Results for: tilray

Tilray Launches High Park Company to Produce And Distribute Adult-Use Cannabis In Canada

High Park Farms in Enniskillen, Ontario

CANADA: In anticipation of the historic legalization of adult-use cannabis in Canada,  Tilray has announced the creation of wholly-owned subsidiary High Park Company to produce and distribute a broad-based portfolio of cannabis brands and products. As a part of this announcement, the company announced it will be making an investment of up to $10 million in a new facility located in Read the full article…

Tilray Signs Letter Of Intent With Pharmasave

Tilray® Signs Letter of Intent with Pharmasave

CANADA:  Tilray Canada announced that it has entered into a Letter of Intent (LOI) to become a preferred medical cannabis supplier to Pharmasave, the premier independent pharmacy banner in Canada. Subject to changes to Canadian regulations that would allow such distribution, Tilray will supply and distribute Good Manufacturing Practices (GMP) certified Tilray-branded medical cannabis products through Pharmasave pharmacists. Read the full article…

Tilray Forms Strategic Alliance With Leading Pharmaceutical Company In Canada

Agreement represents major milestone recognizing medical cannabis as a conventional medicine for patients in need

CANADA: Tilray, a federally licensed producer of medical cannabis, announced today that it has signed a binding letter of intent (LOI) to be the exclusive collaborator of a major pharmaceutical company to accelerate innovation and increase availability of high quality medical cannabis products. Through this LOI and the anticipated definitive agreements, Tilray is allied with Sandoz Read the full article…

Tilray Exports Medical Cannabis To South Africa

Tilray goes to South Africa

First-ever export of plant-derived cannabinoid product to the continent of Africa CANADA: Tilray, a global pioneer in cannabis cultivation, processing and distribution, today announced that it has successfully exported medical cannabis products to South Africa for nationwide distribution to qualified patients through pharmacies. Tilray’s product is the first cannabinoid-based product derived from the cannabis plant that has Read the full article…

Tilray Signs LOI with Société des Alcools du Québec (SAQ) To Supply Province With Cannabis

Tilray Canada inks deal with SAQ

CANADA: Tilray, a global pioneer in cannabis cultivation, processing and distribution, has signed a Letter of Intent (LOI) with Société des alcools du Québec (SAQ) to supply the province of Quebec with high-quality cannabis products in anticipation of adult-use legalization later this year. “This LOI is another major milestone for us as we aim to build Read the full article…

Tilray Announces Completion Of Series A Funding Round Led by Global Institutional Investors

Tilray closes Series A Round

C$60 million Series A financing will enable Tilray to increase production capacity and expand distribution in North America and Europe CANADA:  Tilray has announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors. According to a company press release, Tilray will use Read the full article…

Tilray Exports Medical Cannabis Genetics To The European Union

Europe is going green

PORTUGAL: Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal. The announcement is the first time a company has legally exported live cannabis genetics from North America Read the full article…

Tilray Exports Medical Cannabis Products To New Zealand or Nationwide Distribution

Products currently available in New Zealand include precisely formulated medical cannabis oils containing tetrahydrocannabinol (THC) and cannabidiol (CBD).

CANADA: Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide. The products were produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada and can be dispensed to any patient with valid Read the full article…

Tilray Receives License to Produce Medical Cannabis In The European Union

Tilray to build European Union Campus in Portugal

Company Announces €20 Million Investment to Build EU Campus and Begin Operations this Year PORTUGAL: Tilray has announced plans today to invest up to €20 million in a European Union Campus after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes. “Tilray’s EU Campus is another strategic Read the full article…

Tilray Announces Second Facility To Meet Rapidly Growing Global Demand For Medical Cannabis

Total output to increase to 51 metric tonnes annually by end of 2018

CANADA: Tilray Canada Ltd., a global leader in medical cannabis research and production, has announced that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario. The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will Read the full article…